KALEIDO

Class [005]
Preparations and substances for pharmaceutical and medical purposes, namely, for the treatment of dysbioses, inflammatory disorders and conditions, namely, inflammatory bowel diseases and inflammatory connective tissue diseases, infectious diseases, namely, eye infections, topical infections and urinary tract infections, metabolic diseases, namely, diabetes, hypoglycemia, gout, bulimia nervosa, osteoarthritis and muscular dystrophy, nutritional disorders namely, anemia, malnutrition, immune-mediated diseases, namely, autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's Disease and cerebral palsy, psychiatric conditions, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, namely, dermatitis, eczema, skin pigmentation diseases and psoriaris, cardiovascular diseases, nephrologic diseases and conditions, namely, organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, namely, growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis; therapeutic pharmaceuticals for medical use, namely, for the treatment of dysbioses, inflammatory disorders and conditions, namely, inflammatory bowel diseases and inflammatory connective tissue diseases, infectious diseases, namely, eye infections, topical infections and urinary tract infections, metabolic diseases, namely, diabetes, hypoglycemia, gout, bulimia nervosa, osteoarthritis and muscular dystrophy, nutritional disorders namely, anemia, malnutrition, immune-mediated diseases, namely, autoimmune diseases, allergies, and immune tolerance, malignancies and cancers, neurological diseases, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's Disease and cerebral palsy, psychiatric conditions, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia, gastrointestinal diseases and disorders, gastrointestinal injury conditions, digestive abnormalities, dermatological conditions, namely, dermatitis, eczema, skin pigmentation diseases and psoriaris, cardiovascular diseases, nephrologic diseases and conditions, namely, organ failure, ophthalmic disorders, vaginal and penile conditions, pediatric disorders and conditions, namely, growth and developmental conditions, and geriatric disorders and conditions, all of the foregoing related to the microbiome and all of the foregoing excluding treatments for cystic fibrosis